Related Experiment Video
Updated: May 16, 2026
09:54
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Corticosteroids for the inflammatory response to cardiopulmonary bypass: an update
1Department of Anesthesiology, Intensive Care & Emergency Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. stefandieleman@me.com
Current Pharmaceutical Design
|December 12, 2012
Summary
Intraoperative corticosteroids may reduce systemic inflammation after cardiac surgery. A recent trial on dexamethasone provides new evidence on its clinical effects following cardiopulmonary bypass, impacting patient outcomes.
Area of Science:
- Immunology and inflammation
- Cardiovascular surgery
- Pharmacology
Background:
- Cardiac surgery and cardiopulmonary bypass trigger a significant immune system activation.
- This systemic inflammatory response can lead to severe postoperative complications, including morbidity and mortality.
- Corticosteroids are frequently administered during surgery to prevent this inflammatory response.
Purpose of the Study:
- To review current evidence on corticosteroid use and clinical outcomes after cardiopulmonary bypass.
- To incorporate new findings from a large clinical trial investigating dexamethasone in cardiac surgery.
Main Methods:
- Systematic review of existing literature on corticosteroids in cardiopulmonary bypass.
- Inclusion of data from a recent large-scale clinical trial on dexamethasone.
Main Results:
- Analysis of the impact of corticosteroids on clinical outcomes post-cardiopulmonary bypass.
- Presentation of emerging evidence from the dexamethasone trial.
Conclusions:
- Corticosteroids are a potential prophylactic measure against systemic inflammatory response in cardiac surgery.
- Emerging evidence suggests dexamethasone may influence clinical outcomes in patients undergoing cardiopulmonary bypass.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...